ALK+ mNSCLC is different from other lung cancers

Non-small cell lung cancer, or NSCLC, is a common form of lung cancer. However, a small portion of people with NSCLC—about 5%—have a change in the anaplastic lymphoma kinase, or ALK, gene.

Total NSCLC population

  • This change in the ALK gene results in an abnormal ALK fusion protein

  • The abnormal protein causes this type of lung cancer,  also called ALK+ NSCLC,  to grow and spread to other parts of the body ( ALK+ mNSCLC )

Doctors test people who have NSCLC to find out if they are ALK+. Knowing ALK status helps doctors choose which treatment to prescribe.

An important treatment goal for people who have just learned that they have ALK+ NSCLC that has spread to other parts of the body (mNSCLC) is to help prevent their tumor from further growing or spreading for as long as possible.

Join Staying Positive

Sign up for Staying Positive, an ALECENSA Support Program, for additional tips and resources on living with ALK+ mNSCLC.

Real Talk on ALK+ mNSCLC

Hear from real people living with ALK+ mNSCLC for their advice and experiences.

Patient Support Organizations

Find meaningful education and inspiration from organizations dedicated to helping people living with ALK+ mNSCLC.